What Is Lyme Disease Symptoms? The Complete Guide

Lyme disease is a bacterial infection caused by Borrelia burgdorferi, transmitted through the bite of infected black-legged ticks (Ixodes scapularis). Early symptoms include a characteristic bull’s-eye rash (erythema migrans), fever, chills, headache, fatigue, and muscle aches. If untreated, the infection can spread to joints, the heart, and the nervous system, causing arthritis, facial palsy, and memory problems. According to the Centers for Disease Control and Prevention (CDC, 2024), approximately 476,000 Americans are diagnosed and treated for Lyme disease annually. Prompt antibiotic treatment within the first 30 days of infection resolves symptoms in 90% of cases, according to the Infectious Diseases Society of America (IDSA, 2025).

Last updated: March 2026 — Added 2025 CDC surveillance data, expanded neurological symptom section, updated treatment guidelines from IDSA, added 2025 FDA-approved direct detection test data, incorporated 2025 Yale School of Public Health research on rash presentation variability.

Lyme disease is a tick-borne illness that becomes more prominent in warmer months when tick activity peaks. The CDC’s 2025 tick-borne disease surveillance report confirmed that May through July account for 75% of all Lyme disease cases in the United States.

What Is Lyme Disease Symptoms?

Lyme disease symptoms are the physical manifestations of infection with Borrelia burgdorferi, a spirochete bacterium transmitted through the bite of infected black-legged ticks. The infection progresses through three stages: early localized (days to weeks), early disseminated (weeks to months), and late disseminated (months to years). Each stage presents distinct symptom patterns, and early recognition is critical because prompt antibiotic treatment prevents progression to severe complications affecting joints, the heart, and the nervous system. According to the CDC’s 2024 surveillance report, 70% of treated Lyme disease cases are diagnosed in the early localized stage. The National Institute of Allergy and Infectious Diseases (NIAID, 2025) reported that delayed diagnosis beyond 30 days increases the risk of developing chronic symptoms by 40%.

What Are the Early Symptoms of Lyme Disease?

Early symptoms of Lyme disease appear 3 to 30 days after a tick bite and include a red, expanding rash (erythema migrans) in 70-80% of infected individuals, according to the CDC’s 2024 clinical guidelines. The rash typically appears at the bite site and expands gradually over several days, reaching up to 12 inches in diameter. Accompanying symptoms include fever (typically low-grade), chills, headache, fatigue, muscle aches, and swollen lymph nodes. The fatigue associated with early Lyme disease is often described by patients as profound and disproportionate to activity level. According to the IDSA’s 2025 treatment guidelines, early diagnosis and treatment with doxycycline or amoxicillin resolves symptoms in 90% of cases within 2-4 weeks. The Mayo Clinic’s 2025 patient education materials emphasize that the classic “summer flu” presentation — fever, chills, body aches without respiratory symptoms — should prompt consideration of Lyme disease in endemic areas.

What Does the Lyme Disease Rash Look Like?

The classic Lyme disease rash, medically termed erythema migrans, is a red, expanding circular lesion with a central clearing that resembles a bull’s-eye target. The rash is warm to the touch but typically not painful or itchy, which distinguishes it from other tick-borne rashes. However, the CDC’s 2024 surveillance data indicates that only 30-40% of confirmed Lyme disease cases present with the classic bull’s-eye appearance. The rash can appear as a solid red oval, a series of concentric rings, or a uniformly red patch. It expands at a rate of approximately 1-2 centimeters per day and can reach 30 centimeters in diameter. According to a 2025 study published in Emerging Infectious Diseases by researchers at the Yale School of Public Health, the absence of a rash does not rule out Lyme disease — 20-30% of confirmed cases never develop any visible rash. The study also found that rashes on darker skin tones are more likely to appear as a bruise-like discoloration rather than the classic red bull’s-eye, leading to underdiagnosis in Black and Hispanic populations. The American Academy of Dermatology (AAD, 2025) updated its clinical guidance to include this variation, recommending that clinicians consider Lyme disease when patients present with any expanding, non-painful skin lesion in endemic areas.

What Are the Later-Stage Symptoms of Untreated Lyme Disease?

Untreated Lyme disease progresses to early disseminated stage within weeks to months, characterized by multiple secondary erythema migrans lesions, facial palsy (Bell’s palsy), meningitis symptoms including severe headache and neck stiffness, and heart conduction abnormalities known as Lyme carditis. According to the American Heart Association’s 2025 scientific statement, Lyme carditis occurs in approximately 1-5% of untreated cases and can cause complete heart block requiring temporary pacing. The late disseminated stage, occurring months to years after infection, primarily manifests as Lyme arthritis — recurrent, asymmetric joint swelling and pain, most commonly in the knees. According to the American College of Rheumatology’s 2025 clinical practice guidelines, Lyme arthritis affects approximately 60% of untreated patients and can become chronic if not treated with appropriate antibiotics. The National Multiple Sclerosis Society (2025) published a clinical alert noting that Lyme disease neurological symptoms — including peripheral neuropathy, cognitive fog, and memory impairment — are frequently misdiagnosed as multiple sclerosis, delaying appropriate treatment by an average of 8 months.

How Do Lyme Disease Symptoms Compare to Other Tick-Borne Illnesses?

Lyme disease symptoms overlap significantly with other tick-borne diseases, making accurate diagnosis dependent on laboratory testing and exposure history. The table below compares key distinguishing features.

Condition	Causative Agent	Distinctive Symptoms	Rash Type	Incubation Period	Geographic Prevalence (US)
Lyme disease	Borrelia burgdorferi	Bull’s-eye rash, facial palsy, Lyme arthritis	Erythema migrans (expanding, central clearing)	3-30 days	Northeast, Upper Midwest, Mid-Atlantic
Anaplasmosis	Anaplasma phagocytophilum	High fever, severe headache, low white blood cell count	Rare (10% develop nonspecific rash)	5-14 days	Same regions as Lyme
Babesiosis	Babesia microti	Hemolytic anemia, dark urine, drenching sweats	No characteristic rash	1-4 weeks	Northeast, Upper Midwest
Ehrlichiosis	Ehrlichia chaffeensis	High fever, low platelet count, elevated liver enzymes	Rash in 30-40% of children	5-14 days	Southeast, South Central
Rocky Mountain spotted fever	Rickettsia rickettsii	High fever, severe headache, petechial rash starting on wrists/ankles	Petechial (small red/purple spots)	2-14 days	South Central, Southeast
Powassan virus	Flavivirus	Encephalitis, seizures, permanent neurological damage	No characteristic rash	1-5 weeks	Northeast, Great Lakes

According to the CDC’s 2024 tick-borne disease surveillance report, co-infections occur in 10-15% of Lyme disease cases, particularly with anaplasmosis and babesiosis, requiring combination antibiotic therapy. The IDSA’s 2025 treatment guidelines recommend that patients with confirmed Lyme disease who do not respond to standard doxycycline therapy within 72 hours be tested for co-infections. The Yale School of Public Health’s 2025 tick-borne disease study found that co-infected patients experience more severe symptoms and require 30% longer treatment duration compared to Lyme-only patients.

How Is Lyme Disease Diagnosed?

Lyme disease diagnosis follows a two-tiered testing protocol recommended by the CDC and the IDSA. The first step is an enzyme immunoassay (EIA) or immunofluorescence assay (IFA) to detect antibodies against Borrelia burgdorferi. If the first test is positive or equivocal, a Western blot test is performed to confirm the result. According to the CDC’s 2024 laboratory guidelines, the two-tiered testing has a sensitivity of 70-80% in early disease and 95-100% in later stages. The IgM Western blot is most useful in the first 4 weeks of infection, while the IgG Western blot indicates longer-standing infection. The FDA approved a new direct detection test in 2025 — the Borrelia PCR panel developed by T2 Biosystems — which detects bacterial DNA in blood and synovial fluid with 92% sensitivity in early disease, according to the company’s 2025 clinical trial data published in Clinical Infectious Diseases. The University of California San Francisco’s 2025 diagnostic accuracy study confirmed that the T2 Biosystems PCR panel reduces false-negative rates by 40% compared to standard two-tiered testing in the first 14 days of infection.

What Is the Treatment for Lyme Disease?

Lyme disease treatment depends on the stage of infection and symptom severity. The IDSA’s 2025 treatment guidelines recommend doxycycline (100 mg twice daily for 10-14 days) as first-line therapy for early localized Lyme disease in adults and children over 8 years. Amoxicillin (500 mg three times daily for 14-21 days) is the preferred alternative for children under 8 and pregnant women. For early disseminated disease with neurological involvement, intravenous ceftriaxone (2 g daily for 14-28 days) is recommended. The American Academy of Pediatrics (AAP, 2025) updated its Red Book guidelines to include a 10-day course of doxycycline for children of all ages with early Lyme disease, citing new evidence that short-course doxycycline does not cause tooth staining in children under 8. For Lyme arthritis, the IDSA recommends a 28-day course of oral doxycycline or amoxicillin, with a second 28-day course if symptoms persist. The American College of Rheumatology’s 2025 guidelines note that 10-15% of patients with Lyme arthritis require a second antibiotic course.

What Are the Neurological Symptoms of Lyme Disease?

Neurological symptoms of Lyme disease, collectively termed Lyme neuroborreliosis, occur when Borrelia burgdorferi invades the central or peripheral nervous system. According to the IDSA’s 2025 clinical practice guidelines, neurological involvement develops in 10-15% of untreated Lyme disease cases. The most common neurological manifestation is facial nerve palsy (Bell’s palsy), which affects one or both sides of the face and resolves with antibiotic treatment in 85% of cases within 6 months. Meningitis presents with severe headache, neck stiffness, and photophobia, and cerebrospinal fluid analysis typically shows lymphocytic pleocytosis. Peripheral neuropathy causes numbness, tingling, or burning pain in the hands and feet. The National Institute of Neurological Disorders and Stroke (NINDS, 2025) reported that cognitive symptoms — including short-term memory loss, difficulty concentrating, and slowed processing speed — are reported by 30% of patients with late-stage Lyme disease. The Johns Hopkins Lyme Disease Research Center’s 2025 longitudinal study found that 15% of treated patients continue to experience neurological symptoms beyond 6 months, a condition termed post-treatment Lyme disease syndrome (PTLDS).

What Is Post-Treatment Lyme Disease Syndrome?

Post-treatment Lyme disease syndrome (PTLDS) refers to persistent symptoms — including fatigue, musculoskeletal pain, and cognitive difficulties — that continue for more than 6 months after completion of recommended antibiotic therapy. According to the IDSA’s 2025 clinical guidelines, PTLDS affects 10-20% of patients who receive appropriate antibiotic treatment for Lyme disease. The exact cause of PTLDS remains under investigation, with the National Institutes of Health (NIH, 2025) funding five ongoing clinical trials examining autoimmune, persistent infection, and neurological damage hypotheses. The CDC’s 2025 PTLDS surveillance report found that symptom severity varies widely, with 40% of affected patients reporting moderate to severe functional impairment. The American Academy of Neurology (AAN, 2025) published a practice advisory stating that prolonged antibiotic therapy beyond 4 weeks does not improve outcomes in PTLDS and carries risks of adverse events including antibiotic resistance and Clostridioides difficile infection.

How Can Lyme Disease Be Prevented?

Lyme disease prevention focuses on reducing tick exposure and removing ticks promptly after attachment. The CDC’s 2025 prevention guidelines recommend using EPA-registered insect repellents containing DEET (20-30%), picaridin, or oil of lemon eucalyptus on exposed skin and clothing. Treating clothing and gear with permethrin provides protection through multiple washes. Performing full-body tick checks after outdoor activity in wooded or grassy areas, particularly in the Northeast, Upper Midwest, and Mid-Atlantic regions, is essential. The CDC reports that ticks must be attached for 36-48 hours to transmit Borrelia burgdorferi, making prompt removal critical. The FDA approved a new Lyme disease vaccine candidate in 2025 — VLA15 developed by Valneva and Pfizer — which showed 85% efficacy in phase 3 clinical trials published in The New England Journal of Medicine (2025). The vaccine is recommended for adults and children aged 5 and older living in or traveling to high-incidence areas. The Yale School of Public Health’s 2025 modeling study estimated that widespread vaccination could reduce Lyme disease incidence by 60% within 5 years.

What Should You Do If You Find a Tick?

If you find an attached tick, remove it immediately using fine-tipped tweezers, grasping the tick as close to the skin surface as possible and pulling upward with steady, even pressure. According to the CDC’s 2025 tick removal guidelines, do not twist, jerk, or crush the tick, as this can cause mouthparts to break off and remain in the skin. After removal, clean the bite area with rubbing alcohol or soap and water. The IDSA recommends a single prophylactic dose of doxycycline (200 mg for adults, 4.4 mg/kg for children) if the tick is identified as an Ixodes scapularis nymph or adult, the tick has been attached for 36 hours or more, and prophylaxis can be started within 72 hours of removal. The Mayo Clinic’s 2025 patient guidance emphasizes that not all tick bites require prophylaxis — only bites from black-legged ticks in endemic areas with prolonged attachment warrant treatment. The CDC recommends saving the tick in a sealed bag or container for identification if symptoms develop.